To achieve this, we studied tumor cell proliferation based on the immunohistochemical markers Ki-67 and MCM6, which are associated with histopathological factors such as WHO grade and mitotic index on one hand and genome-wide DNAm profiles of a meningioma cohort composed of 48 tumor tissues of various grades on the other hand. The gene discussed is MCM6; the disease is neoplasm.